Study details
Enrolling now
Haploidentical Transplant Trial
University of Wisconsin, Madison
NCT IDNCT02508038ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
22
Study length
about 12 years
Ages
0.583333333333333–21
Locations
1 site in WI
About this study
This trial is testing the safety of a transplant using stem cells from a partially matched donor, combined with Zoledronate medication, in children with certain cancers. The goal is to see if this treatment helps patients who have relapsed or become resistant to other treatments.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Zoledronate
- 2.Undergo TCRαβ+/CD19+ depleted Haploidentical HSCT
PhasePhase 1
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Oncology